Inspire(US:INSP) Globenewswire·2025-11-19 21:38Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to allegations of false statements regarding the launch of its new product, Inspire V, which reportedly failed to meet demand and lacked necessary preparations for a successful rollout [3][4]. Group 1: Allegations and Issues - The complaint alleges that the launch of Inspire V was poorly executed, with significant surplus inventory and reluctance from providers to adopt the new treatment [3]. - Defendants are accused of making misleading statements about the launch's success, despite failing to complete essential tasks such as training for treatment center customers and setting up necessary IT systems [3]. - Critical issues included the lack of updated claims processing software and the absence of Medicare reimbursement at the time of the product launch [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as August 6, 2024, to August 4, 2025, with a deadline for shareholders to register as lead plaintiffs by January 5, 2026 [4]. - Shareholders who purchased shares during the specified timeframe are encouraged to register for the class action, which includes portfolio monitoring for case updates [4]. - Participation in the case does not incur any costs or obligations for the shareholders [4].